Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma

Figure 6

Kaplan-Meier analysis of overall survival grouped by stage and risk score combination. (a) Eight groups by stage and risk score. (b) Four stages. (c) Group 1 (stage 0 and low risk) and Group 2 (stage 0 and high risk). (d) Group 3 (stage I and low risk) and Group 4 (stage I and high risk). (e) Group 5 (stage II and low risk) and Group 6 (stage II and high risk). (f) Group 7 (stage III and low risk) and Group 8 (stage III and high risk). (g) Group 2 and Group 3. (h) Group 4 and Group 5. (i) Group 6 and Group 7. (j) Group 6 and Group 8.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)